Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma-Reference-Cited by-同舟云学术

Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma

Published:2005-04 Issue:2 Volume:12 Page:99-103
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Iwata Hiroji,Nakamura Seigo,Toi Masakazu,Shin Eisei,Masuda Norikazu,Ohno Shinji,Takatsuka Yuichi,Hisamatsu Kazufumi,Yamazaki Kosuke,Kusama Mikihiro,Kaise Hiroshi,Sato Yasuyuki,Kuroi Katsumasa,Akiyama Futoshi,Tsuda Hitoshi,Kurosumi Masafumi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.springerlink.com/index/pdf/10.2325/jbcs.12.99

Reference14 articles.

1. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown Ann, Fisher ER, Wicerham DL, Begovic M, DeCillis A, Robidoux A, Margolese RG, Cruz AB, Hoen JL, Lees AW, Dimitrov NV, Bear HD: Effect of prospective chemotherapy on the outcome of women with operable breast cancer.J Clin Oncol 16:2672–2685, 1998.

2. Van der Huge JA, Van der Velde CJH, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L; Cooperating investigators: Preoperative chemotherapy in primary operable breast cancer: results from the European organization for research and treatment of cancer trial 10902.J Clin Oncol 19:4224–4237, 2001.

3. Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, Theriault RL, Singh G, Binkley SM, Sneige N, Buchhols TA, Ross MI, McNeese MD, Buzdar AU, Hortobagyi GN, Eva Singletary S: Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorabicine-based neoadjuvant chemotherapy.J Clin Oncol 17:460–469, 1999.

4. Scholl SM, Fourqeet A, Asselain B, Pierga JY, Vilcoq JR, Durand JC, Dorval T, Palangie T, Louve M, Beuzeboc P: Neoadjuvant versus adjuvant chemotherapy in premonopausal patients with tumours considered too large for breast conserving surgery preliminary results of a randomized trial: S6.Eur J Cancer 30:645–652, 1994.

5. Mauriac L, MacGrogan G, Avril A, Durand M, Floquet A, Deblet M, Dihuydy JM, Bonichon F: Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow up. Institut Bergoni Bordeaux Groupe Sein (IBBGS).Ann Oncol 10:47–52, 1999.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study;Breast Care;2024

2. Randomized Multicenter Phase II Trial of Neoadjuvant Therapy Comparing Weekly Nab-paclitaxel Followed by FEC With Docetaxel Followed by FEC in HER2− Early-stage Breast Cancer;Clinical Breast Cancer;2018-12

3. Epirubicina neoadyuvante con o sin docetaxel secuencial en el tratamiento del cáncer de mama avanzado: evaluación de la respuesta patológica completa y tolerabilidad de la quimioterapia;Cirugía y Cirujanos;2018-11-21

4. Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy;New England Journal of Medicine;2017-06

5. Análisis de la efectividad del tratamiento neoadyuvante al añadir docetaxel secuencial a fluorouracilo, epirrubicina y ciclofosfamida en pacientes con cáncer de mama avanzado: resultados preliminares de respuesta tumoral;Gaceta Mexicana de Oncología;2015-01